YakubovAlim/iStock via Getty Images
Gilead Sciences (GILD) is scheduled to report a 3% fall in its Q4 earnings, scheduled for February 10, after the closing bell.
The consensus EPS Estimate is $1.83 on revenue of $7.68B, which translates to a 1.5% jump compared to the corresponding quarter